INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER, UNIVERSITE DE MONTPELLIER FILES APPLICATION FOR "USE OF THE PPARD/PDK4/ANGPTL4 PATHWAY AS A BIOMARKER AND BIOTARGET OF MOTILITY DISORDERS IN PATIENTS WITH OBESITY"

GENEVA, March 30 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (3, Rue Michel Ange75016 Paris), CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER (191, Avenue Doyen Gaston Giraud34000 Montpellier), UNIVERSITE DE MONTPELLIER (163, rue Auguste Broussonnet34090 Montpellier) filed a patent application (PCT/EP2025/076360) for " USE OF THE PPARD/PDK4/ANGPTL4 PATHWAY AS A BIOMARKER AND BIOTARGET OF MOTILITY DISORDERS IN PATIENTS WITH OBESITY " on Sep 16, 2025. With publication no. WO/2026/061981, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classi...